ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/11/24 | 1,973 | 1,975 | 1,955 | 1,975 | +22 | +1.1% | 70,700 |
2023/11/22 | 1,942 | 1,965 | 1,942 | 1,953 | +11 | +0.6% | 79,000 |
2023/11/21 | 1,923 | 1,944 | 1,918 | 1,942 | +21 | +1.1% | 69,500 |
2023/11/20 | 1,944 | 1,953 | 1,918 | 1,921 | -15 | -0.8% | 93,800 |
2023/11/17 | 1,917 | 1,936 | 1,907 | 1,936 | +32 | +1.7% | 80,700 |
2023/11/16 | 1,902 | 1,924 | 1,896 | 1,904 | +2 | +0.1% | 98,900 |
2023/11/15 | 1,907 | 1,913 | 1,886 | 1,902 | +7 | +0.4% | 86,900 |
2023/11/14 | 1,889 | 1,907 | 1,881 | 1,895 | +6 | +0.3% | 78,200 |
2023/11/13 | 1,920 | 1,920 | 1,880 | 1,889 | -18 | -0.9% | 101,400 |
2023/11/10 | 1,891 | 1,907 | 1,881 | 1,907 | +4 | +0.2% | 102,400 |
2023/11/09 | 1,916 | 1,919 | 1,885 | 1,903 | -7 | -0.4% | 128,700 |
2023/11/08 | 1,934 | 1,936 | 1,894 | 1,910 | -12 | -0.6% | 188,300 |
2023/11/07 | 1,945 | 1,957 | 1,920 | 1,922 | -25 | -1.3% | 130,200 |
2023/11/06 | 1,999 | 2,000 | 1,945 | 1,947 | -21 | -1.1% | 169,600 |
2023/11/02 | 1,946 | 1,983 | 1,912 | 1,968 | -80 | -3.9% | 264,400 |
2023/11/01 | 2,011 | 2,050 | 2,008 | 2,048 | +52 | +2.6% | 170,900 |
2023/10/31 | 1,970 | 1,998 | 1,967 | 1,996 | +34 | +1.7% | 118,500 |
2023/10/30 | 1,991 | 1,991 | 1,951 | 1,962 | -49 | -2.4% | 122,700 |
2023/10/27 | 1,987 | 2,011 | 1,970 | 2,011 | +48 | +2.4% | 70,800 |
2023/10/26 | 1,990 | 2,002 | 1,963 | 1,963 | -16 | -0.8% | 108,100 |
2023/10/25 | 1,999 | 1,999 | 1,977 | 1,979 | -8 | -0.4% | 108,200 |
2023/10/24 | 2,000 | 2,008 | 1,954 | 1,987 | -8 | -0.4% | 102,800 |
2023/10/23 | 1,989 | 2,017 | 1,988 | 1,995 | -13 | -0.6% | 145,400 |
2023/10/20 | 1,989 | 2,017 | 1,982 | 2,008 | -1 | ±0% | 121,200 |
2023/10/19 | 2,018 | 2,040 | 2,009 | 2,009 | -33 | -1.6% | 102,200 |
2023/10/18 | 2,025 | 2,050 | 2,003 | 2,042 | +22 | +1.1% | 102,500 |
2023/10/17 | 2,021 | 2,045 | 2,015 | 2,020 | -22 | -1.1% | 156,300 |
2023/10/16 | 2,058 | 2,060 | 2,021 | 2,042 | -16 | -0.8% | 75,900 |
2023/10/13 | 2,094 | 2,094 | 2,056 | 2,058 | -56 | -2.6% | 98,400 |
2023/10/12 | 2,123 | 2,135 | 2,111 | 2,114 | -6 | -0.3% | 58,400 |
2023/10/11 | 2,144 | 2,150 | 2,120 | 2,120 | -24 | -1.1% | 52,200 |
2023/10/10 | 2,117 | 2,152 | 2,112 | 2,144 | +7 | +0.3% | 126,300 |
2023/10/06 | 2,116 | 2,158 | 2,113 | 2,137 | +40 | +1.9% | 117,500 |
2023/10/05 | 2,081 | 2,108 | 2,077 | 2,097 | -4 | -0.2% | 162,900 |
2023/10/04 | 2,110 | 2,142 | 2,073 | 2,101 | -18 | -0.8% | 102,900 |
2023/10/03 | 2,170 | 2,179 | 2,119 | 2,119 | -55 | -2.5% | 116,000 |
2023/10/02 | 2,202 | 2,228 | 2,174 | 2,174 | -45 | -2% | 135,400 |
2023/09/29 | 2,235 | 2,235 | 2,205 | 2,219 | -20 | -0.9% | 100,200 |
2023/09/28 | 2,255 | 2,273 | 2,223 | 2,239 | -66 | -2.9% | 121,700 |
2023/09/27 | 2,270 | 2,306 | 2,252 | 2,305 | +47 | +2.1% | 228,400 |
2023/09/26 | 2,278 | 2,287 | 2,254 | 2,258 | -46 | -2% | 166,800 |
2023/09/25 | 2,272 | 2,306 | 2,265 | 2,304 | +33 | +1.5% | 135,000 |
2023/09/22 | 2,282 | 2,299 | 2,260 | 2,271 | -31 | -1.3% | 115,000 |
2023/09/21 | 2,330 | 2,331 | 2,297 | 2,302 | -18 | -0.8% | 91,100 |
2023/09/20 | 2,363 | 2,380 | 2,320 | 2,320 | -52 | -2.2% | 114,600 |
2023/09/19 | 2,378 | 2,388 | 2,354 | 2,372 | -26 | -1.1% | 127,900 |
2023/09/15 | 2,247 | 2,400 | 2,247 | 2,398 | +1 | ±0% | 235,900 |
2023/09/14 | 2,400 | 2,405 | 2,391 | 2,397 | -24 | -1% | 110,600 |
2023/09/13 | 2,407 | 2,428 | 2,389 | 2,421 | -11 | -0.5% | 102,900 |
2023/09/12 | 2,381 | 2,432 | 2,381 | 2,432 | +36 | +1.5% | 132,000 |
351~
400
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.47倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 523,000円 | +7.1% | -35.0% | 2.29% | 43.25倍 | 1.21倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.66倍 | 0.82倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.05倍 | 3.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
市場注目の銘柄
チャート関連のコラム